For 27 years, the Johnson & Johnson Human Performance Institute has helped people find better life balance. Step inside the Institute’s innovative new facility, and see how the staff helps clients reboot, recharge, and discover their personal purpose: https://goo.gl/LFKZim | Johnson & Johnson

JUST IN: A preclinical study published in Nature shows that Johnson & Johnson’s investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. According to the World Health Organization, as of July 2020, global cases have now surpassed 16 million. Learn more about the study’s findings and how J&J is harnessing its science, scale and expertise to help fight the pandemic. | Johnson & Johnson

A preclinical study published in Nature about an investigational COVID-19 vaccine shows that it provides robust protection against the coronavirus. In this special episode, Lisa Ling talks to Johnson & Johnson’s Chief Scientific Officer Paul Stoffels, M.D. and Harvard’s Dan Barouch, M.D., Ph.D. about why these early results are encouraging. | Johnson & Johnson

Johnson & Johnson announced that the CDC Advisory Committee recommends our single-dose COVID-19 vaccine for individuals age 18 and older, under the Emergency Use Authorization issued by the U.S. FDA. Read more: https://bit.ly/3r8ovfO The Janssen COVID-19 Vaccine has not been approved or licensed by FDA: https://bit.ly/2NKFjLs | Johnson & Johnson